Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.410
-0.080 (-1.78%)
At close: Sep 4, 2026, 4:00 PM EDT
4.290
-0.120 (-2.72%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $276.74 million as of September 4, 2026. Its market cap has increased by 873.51% in one year.
Market Cap
276.74M
Enterprise Value
192.72M
1-Year Change
873.51%
Ranking
Category
Stock Price
$4.41
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $276.74M, an increase of 32.70%. That is a compound annual growth rate of 16.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 276.74M | -12.98% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 294.94M |
| Fulcrum Therapeutics | 292.98M |
| AC Immune | 291.32M |
| Fate Therapeutics | 289.97M |
| Foghorn Therapeutics | 289.21M |
| Orchestra BioMed Holdings | 284.90M |
| ALX Oncology Holdings | 280.70M |
| Alector | 280.26M |